Louise Barrett | executive |
Corey Fishman | executive |
Judith Matthews | executive |
Jason Mccarthy | analyst |
Good morning, everyone. Welcome to Iterum Therapeutics Second Quarter 2024 Financial Results and Business Update. My name is Kiki, and I will be your conference operator today. [Operator Instructions] I will now hand you over to your host, Louise Barrett, Senior Vice President, Legal Affairs, to begin. Louise, please go ahead.